Skin Therapeutic

SkinBioTherapeutics is a life science company focused on harnessing the power of the microbiome to develop novel treatments for skin health. Spun out of the University of Manchester, the company utilizes its proprietary SkinBiotix platform to create probiotic-derived lysates that enhance the skin's natural barrier function and protect against infection. Their lead commercial product, AxisBiotix-Ps, is a food supplement designed to manage the symptoms of psoriasis via the gut-skin axis. The company is also advancing programs in eczema (MediBiotix) and skin aging, while exploring partnerships for large-scale commercialization in the global skincare and dermatology markets.